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Ubiquitin specific peptidase 9 (USP9) is a deubiquitinase encoded by a sex-linked gene with a Y-
chromosomal form (USP9Y) and an X-chromosomal form (USP9X) that escapes X-inactivation. Since 
USP9 is a key regulatory gene with sex-linked expression in the human brain, the gene may be of 
interest for researchers studying molecular gender differences and ubiquitin signaling in the brain. 
To assess the downstream effects of knocking down USP9X and USP9Y on a transcriptome-wide scale, 
we have conducted microarray profiling experiments using the human DU145 prostate cancer cell 
culture model, after confirming the robust expression of both USP9X and USP9Y in this model. By 
designing shRNA constructs for the specific knockdown of USP9X and the joint knockdown of USP9X and 
USP9Y, we have compared gene expression changes in both knockdowns to control conditions to infer 
potential shared and X- or Y-form specific alterations. Here, we provide details of the corresponding 
microarray profiling data, which has been deposited in the Gene Expression Omnibus database (GEO 
series accession number GSE79376). A biological interpretation of the data in the context of a potential 
involvement of USP9 in Alzheimer’s disease has previously been presented in Köglsberger et al. (2016). 
To facilitate the re-use and re-analysis of the data for other applications, e.g. the study of ubiquitin 
signaling and protein turnover control, and the regulation of molecular gender differences in the human 
brain and brain-related disorders, we provide a more in-depth discussion of the data properties, 
specifications and possible use cases. 
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Specifications Table 
Subject area Biology 
More specific subject 
area 
Ubiquitin signaling 
Type of data Microarray gene expression data 
How data was acquired Gene expression profiling using Affymetrix Human Gene 2.0 ST arrays on 
an Affymetrix GeneChip Scanner 3000 
Data format Raw (CEL files) and preprocessed and normalized data using the GC-RMA 
approach 
Experimental factors Expression profiling was performed with triplicate samples for each of the 
following five considered conditions: USP9X/Y knockdown, USP9X 
knockdown, scrambled RNA control, transfection reagent control, and 
unperturbed control. 
Experimental features DU145 prostate cancer cells were transfected with shRNA constructs for 
the knockdown of USP9X/Y and USP9X knockdown using the 
Lipofectamine 2000 transfection reagent (control samples included a 
scrambled RNA control, a transfection reagent control, and an 
unperturbed control). Total RNA was extracted using the Qiagen RNeasy 
Mini Kit (Qiagen #74106) and treated with DNaseI (Qiagen #79254). 
Data source location Luxembourg Centre for Systems Biomedicine (LCSB), University of 














Data accessibility Data is accessible through the NCBI GEO database. The series record ID is 




Köglsberger S, Cordero-Maldonado MLL, Antony P, Forster JII, Garcia P, 
Buttini M, Crawford A, Glaab E (2016) Gender-specific expression of 
ubiquitin-specific peptidase 9 modulates tau expression and 




Value of the data 
 
• Since USP9 has been implicated as a key sex-linked regulatory gene in neurodegenerative 
diseases, altering the degradation of alpha-synuclein in Parkinson’s disease [1, 2], enhancing the 
toxicity of amyloid-beta 42 expression in a Drosophila Alzheimer’s model [3], and modulating 
the gene expression of the Alzheimer’s associated protein tau [4], the information provided in 
the data on USP9 knockdown effects may help researchers to study the specific functional roles 
for both the X- and Y-form of USP9 in the context of multiple complex human diseases.  
 
• USP9 is a prime example for a sex-linked gene with an X-form that escapes X-inactivation [5]. For 
researchers studying other gonosomal genes, the data could therefore provide a reference to 
test analysis methods to assess shared and differential knockdown effects for the X- and Y-form 
of sex-linked genes, and to compare the results with other genes. 
 
• Transcriptome-wide measurement data reflecting the downstream effects of knockdowns for 
key regulatory genes involved ubiquitin signaling and protein turnover control is scarce. Thus, 
the data presented here may serve both as a pilot dataset to prepare similar studies for other 
deubiquitinases and ubiquitinases and to compare the results across different studies. 
 
Data 
Transcriptome-wide gene expression profiles of human DU145 prostate cancer cells were obtained for 
two different shRNA-knockdowns, one specific for the X-form of the gene USP9 (USP9X) and one 
combined knockdown of both the X- and Y-form of the gene (USP9X/Y, used to infer potential USP9Y-
specific gene expression changes indirectly by comparing both knockdowns). The data additionally 
covers transcriptome measurements for three control conditions to assess the significance and 
specificity of the knockdown effects: A scrambled RNA control, a transfection reagent control, and an 
unperturbed control. For each of these target and control conditions, three replicates are included to 
account for biological and technical variation in subsequent statistical analyses. Apart from the raw 
microarray measurements in Affymetrix CEL-file format, we also provide the pre-processed data 
obtained from applying the GC-RMA approach for background correction, normalization and probe 













expressed genes between USP9X and USP9Y combined knockdowns and control samples in this dataset, 
a volcano plot was generated (Figure 1) and the top 50 differentially expressed unique genes with 
known gene symbols were visualized in a heat map (Figure 2). Finally, to compare the expression 
changes in the two knockdowns against each other, a correlation plot of transcript log fold changes in 
the USP9X knockdown samples compared to controls vs. the transcript log fold changes in the USP9X/Y 
knockdown samples was created (Figure 3). 
 
Experimental Design, Materials and Methods 
 
Cell culture knockdown experiments 
DU145 cells (ATCC #HTB-81) were cultured in Dulbecco's modified eagle medium (Gibco #41966-029), 
supplemented with 10% v/v heat-inactivated fetal bovine serum (Gibco #10500-064). Knock-down 
plasmids were designed to either jointly target USP9X and USP9Y or only target USP9X. Since USP9X and 
USP9Y have a high sequence homology, no potentially unspecific USP9Y shRNA plasmids were 
generated. Hairpin sequences and U6 promoters were subcloned into FastBac plasmids [7] (see [4] for 
details on the primers tested and the agarose gel electrophoresis results). Only one shRNA construct for 
each target was used, and since off-target effects can occur and the gene silencing efficiency may vary 
for different constructs, limitations may arise when interpreting data derived from a single construct. 
However, since the expression analysis only showed a highly significant inhibition of the target genes 
and no matched or similar effects for any other gene, we can exclude strong off-target changes and that 
larger amounts of target transcripts escape the inhibition to recover normal function. Cells were 
transfected via lipofectamine 2000 (ThermoFisher/Invitrogen #11668019) and incubated for 48h. 
 
Cell sorting, RNA isolation and Microarray experiments 
Before extracting RNA, the perturbed cells were enriched via fluorescence-activated cell sorting. The 
Qiagen RNeasy Mini Kit (Qiagen #74106) and DNaseI (Qiagen #79254) were used to extract and treat the 
RNA, respectively. Reverse transcription was done as described previously [8]. RNA extracts were 
prepared for the microarray experiments using the GeneChip WT PLUS Reagent Kit (Affymetrix, Manual 
P/N 703174 Rev. 2 and User Manual GeneChip Expression Wash, Stain and Scan for Cartridge Arrays P/N 
702731 Rev. 4). A NanoDrop ND-100 (Thermo Scientific) and the 2100 Agilent Bioanalyzer (Agilent) were 
used to check RNA quality and integrity, respectively. The purified, sense-strand cDNA was fragmented 
by uracil-DNA glycosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE 1) at the unnatural 
dUTP residues. The fragmented cDNA was labelled by terminal deoxynucleotidyl transferase (TdT) using 
the Affymetrix proprietary DNA Labelling Reagent covalently linked to biotin. 5.5 μg of single-stranded 
cDNA was used for fragmentation and labelling, and the GeneChip Hybridization, Wash and Stain Kit was 
used to hybridize and wash the cartridges. Control Oligonucleotide B2 and 20X Eukaryotic Hybridization 
Controls were added to the hybridization cocktail containing the labelled sample and injected into the 
cartridge. Incubation lasted 16 hrs. at 45°C with rotation at 60 rpm. Next, the Fluidics Station 450/250 
was used to wash and stain the Affymetrix GeneChip Human Gene 2.0 ST probe arrays. Using the 















Microarray data processing and visualization 
The raw microarray dataset was pre-processed and normalized using the GC-RMA approach [6], and the 
raw and processed data have both been made available in the Gene Expression Omnibus (GEO) 
database (series accession number GSE79376). Differentially expressed genes between different 
knockdown conditions (USP9X only and USP9X/Y combined knockdown) and control conditions were 
assessed using the empirical Bayes moderated t-statistic [9]. To adjust the resulting p-values for multiple 
hypothesis testing the Benjamini–Hochberg procedure was applied [10]. Gene expression patterns were 
visualized using a volcano plot to highlight altered patterns of gene expression between USP9X and 
USP9Y combined knockdowns and control samples (Figure 1). The volcano plot compares the negative 
logarithm to base 10 of the adjusted p-values against the log fold change, revealing that numerous 
genes display alterations with high effect size and high significance. As a complementary visualization, a 
heat map and cluster dendrogram was generated for the top 50 shared differentially expressed 
unique genes with known gene symbols in the USP9XY and USP9X knockdowns compared to control 
samples, using hierarchical average linkage agglomerative clustering with a Pearson correlation distance 
metric (Figure 2). These top 50 genes include USP9X as the gene with the most significant decrease in 
expression levels. To further confirm the successful knockdowns for USP9X and USP9Y/X, we determined 
the median log fold changes and p-values for all genetic probes mapping to these genes. For the 
USP9X/Y knockdown, a strong under-expression was observed for both the USP9X and the USP9Y gene 
(median log. fold change (logFC) USP9X: -2.8, median p-value USP9X: 1.1E-05; median logFC USP9Y: -
1.4, median p-value USP9Y: 6.1E-03). For the USP9X knockdown, lower average expression levels for 
USP9X were also observed, but with a weaker effect (median logFC: -0.46, median p-value: 2.6E-01). To 
assess the similarity between the expression alterations for the two knockdowns, a correlation plot was 
generated, comparing the transcript log fold changes for the USP9X knockdown against those in the 















Figure 1: Volcano plot to visualize differential gene expression between USP9X and USP9Y combined 
knockdowns and control samples. For each transcript, the negative logarithm to base 10 for the adjusted 
p-value is plotted against the log fold change. To highlight transcripts with high effect size and 
significance, data points are colored orange if the absolute value of the log fold change is above 1, and 
green if additionally, the adjusted p-value is below 0.05 (all other data points are shown in black). For 
the data points that pass both these effect size and significance filters, the HGNC gene symbols and 





























Figure 2: Heat map for the top 50 shared differentially expressed unique genes with known gene 
symbols in the USP9XY and USP9X knockdowns. On the right, the standard HGNC symbols for these 
genes are provided, as well as the IDs of the corresponding microarray genetic probe sets (shown in 
brackets). The heat map color codes represent row-wise Z-scores computed for the gene expression 





Figure 3: Correlation plot of gene expression log fold changes in the USP9X knockdown samples 













point corresponds to one genetic probe. The genetic probes with the largest differences in log fold 
changes between the two knockdowns are highlighted by bold colored points (red = higher log fold 
changes in the USP9X knockdown, red = higher log fold changes in the USP9X/Y knockdown) and the 
corresponding HGNC gene symbols and genetic probe IDs (in brackets) are displayed next to these 
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